Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySalePaul R. Fonteyne
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-42.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Paul R. Fonteyne: trading record in brief
Paul R. Fonteyne is a declared insider at 4 companies (senior executive); the most frequent names are Apellis Pharmaceuticals, Inc., Covetrus, Inc. and Amylyx Pharmaceuticals, Inc. In total, 11 filings cover trades dated from 10 August 2021 to 14 May 2026.
Every open-market trade on record is a purchase: 2 purchases worth €165k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 1 option exercise.
The newest entry dates from 14 May 2026: a transaction, in Apellis Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,742 days ago, on 10 January 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul R. Fonteyne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
30,666 sharesCommon StockSEC:0001193125-26-224618:0
7,961 shares0Common StockSEC:0001492422-26-000010:0
6,267 shares0Common StockSEC:0001127602-25-000425:0
3,341 shares0Common StockSEC:0001127602-24-000120:0
3,867 shares0Common StockSEC:0000899243-23-000668:0
13,275 shares0Common StockSEC:0001752836-22-000143:0
8,275 shares0Common StockSEC:0001752836-22-000098:0
53,832 sharesCommon StockSEC:0001104659-22-057532:0
3,947 shares@ US$19.000.0045% mcap50.0% of flowCommon StockSEC:0000899243-22-001527:0
Canonical exit: 6 Apr 2022 (T+90)
4,230 shares0Common StockSEC:0001127602-22-000726:0
5,000 shares@ US$23.24100.0% of flowCommon StockSEC:0001752836-21-000236:0
Canonical exit: 8 Nov 2021 (T+90)
11 of 11 declarations
